Fig. S1.

OXT compared with placebo treatment did not ameliorate nonsocial core or associated features of autism spectrum disorder. (A) No significant difference was observed between posttreatment repetitive behaviors as measured by the RBS-R Total Score. (B) No significant difference was observed between posttreatment anxiety symptoms as measured by the Spence Children’s Anxiety Scale Total Score. Data are corrected for the blocking factors in the analysis and are presented as least squares mean ± SE.